Incannex Approved To Commence Phase 1 Clinical Trial Of CBD Based Anti-Inflammatory Drug
[ad_1] Incannex Healthcare Limited IXHL IHL has received approval from the Bellberry Human Research Ethics Committee (‘HREC’) for a phase 1 clinical trial investigating its proprietary multi-use, anti-inflammatory drug IHL-675A.…